Physician profile

Michael Zachareas

Urology · Beverly, MA

NPI 1528000254

$26,870.38

in general payments reported to CMS, 2019-2025

49 companies · $5,824 in 2025

The $5,824 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,878.72
Consulting Fee$2,172.50
Education$71.12

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $3,414.32 2021-2025 Interstim, Altaviva
Ferring Pharmaceuticals INC. $2,896.41 2024-2025 Adstiladrin
Axonics, INC. $2,850.85 2020-2024 Axonics, Bulkamid
Teleflex LLC $2,341.69 2021-2025 Urolift, Barrigel
Astellas Pharma US INC $2,053.92 2019-2025 Myrbetriq, Xtandi
Neotract INC. $1,849.45 2019-2020
Endo Pharmaceuticals INC. $1,297.18 2019-2024 Aveed, Xiaflex
Antares Pharma, INC. $1,250.81 2019-2025 Xyosted, Nocdurna, Tlando
Janssen Biotech, INC. $1,217.99 2019-2025 Erleada, Akeega
Urogen Pharma, INC. $680.69 2020-2025
Coloplast Corp $510.42 2019-2025 Speedicath
Abbvie INC. $466.90 2019-2025 Botox, Lupron Depot
Medtronic USA, INC. $463.20 2019-2020
Endo USA, INC. $416.85 2024-2025 Xiaflex, Aveed
Alnylam Pharmaceuticals INC. $413.67 2021-2025 Givlaari
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $395.54 2019-2022
Tolmar Pharmaceuticals, INC. $365.60 2019-2022
Calyxo, INC. $326.95 2025 Cvac Aspiration System
Dendreon Pharmaceuticals LLC $294.74 2019-2025 Provenge
Laborie Medical Technologies Corp. $282.46 2024-2025 Optilume Bph Drug Coated Balloon Catheter
Sumitomo Pharma America, INC. $258.15 2023-2025 Gemtesa, Orgovyx
Pfizer INC. $242.40 2019-2020
Blue Earth Diagnostics $224.44 2019-2022
Aytu Biopharma, INC. $224.10 2019-2020
Tolmar, INC. $221.72 2023-2025 Jatenzo, Eligard
Myriad Genetic Laboratories, INC. $213.55 2021-2025 Prolaris, Myrisk
Acerus Pharmaceuticals Corporation $201.87 2020-2022
Accord Healthcare, INC. $163.43 2022
Boston Scientific Corporation $152.07 2024 Ams 700
180 Medical, INC. $126.26 2019-2021
Progenics Pharmaceuticals, INC. $98.30 2023-2025 Pylarify
Halozyme INC $93.30 2023
Myovant Sciences INC. $88.21 2021-2022
Urovant Sciences INC $76.44 2021-2022
Valencia Technologies Corporation $75.83 2025 Ecoin Device Kit
Olympus America INC. $75.24 2025 Itind System
Hollister Incorporated $74.37 2021-2024 Vapro Plus Pocket
Merck Sharp & Dohme LLC $68.00 2020-2025 Keytruda, Lynparza
Amgen INC. $65.55 2019-2020
Abc Home Medical Supply, INC. $57.70 2024
Karl Storz Lithotripsy-America $53.18 2019
Procept Biorobotics Corporation $35.69 2024 Aquabeam System
Kowa Pharmaceuticals America, INC. $35.59 2022
Immunitybio, INC. $31.24 2025
Bluewind Medical $27.39 2024 Revi
Astrazeneca Pharmaceuticals LP $27.26 2020
Bayer Healthcare Pharmaceuticals INC. $24.99 2022
Tempus Ai, INC $23.17 2024 Xt Cdx
Sun Pharmaceutical Industries INC. $21.30 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael Zachareas

$26,870.38

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $5,824 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/68820/michael-zachareas

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.